Samoan Tech Currents: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Samoan Tech Currents.

Press releases published on September 22, 2026

Opterion Health gibt positive Ergebnisse der Phase-1-Studie für OPT101 bekannt, die den Übergang zur Phase 2a ermöglichen
オプテリオン・ヘルス、OPT101の第1相試験で、第2a相試験への移行を裏付ける良好な結果を発表
Opterion Health 宣布 OPT101 的 1 期临床试验结果积极,支持推进至 2a 期研究
Cloudera Named a Leader in the 2026 IDC MarketScape for Asia/Pacific Sovereign AI Platforms
Frequency Holdings FRQN Reduces Authorized Common Shares from 5.4 Billion to 250 Million - Creating Valuable Structure for Revenue and Market Growth
Digital Realty to Develop New Cable Landing Station in Los Angeles
Monk Launches Knowledge, where finance teams store the context Their AI Agents Run On
Xanadu Appoints Tara Deakin as Chief People Officer to Lead Next Phase of Global Growth
Voting Rights and Shares Capital of the Company
Information mensuelle relative au nombre total de droits de vote  et d’actions composant le capital social
Progress Software Completes Acquisition of Domo's AI and Data Platform Business
Biomea Fusion Announces Proposed Public Offering of Securities
The Elmet Group Secures Long-Term Tungsten Offtake Agreement with Tungsten West’s Hemerdon Mine
AesthetiClinic Launches Booking and Compliance Platform for Independent Aesthetic Practitioners
Inkoop van eigen aandelen
Acquisition of Own Shares
IN8bio to Present at Sidoti Small-Cap Virtual Conference
CambriLearn shortlisted for Best Online School in the UAE
Lantronix Nominates Defense Technology Executive and Former Navy SEAL Jason Lamb to Board of Directors
NeOnc’s Delivery may Finally Change the Equation for Brain Cancer’s Next Frontier

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Samoan Tech Currents

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.